These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2017446)

  • 21. Potent cholecystokinin antagonist L 364718 stimulates food intake in rats.
    Reidelberger RD; O'Rourke MF
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1512-8. PubMed ID: 2481407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
    Kelland MD; Zhang J; Chiodo LA; Freeman AS
    Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L364.718 during suckling on the sensitivity to the hypophagic effect of cholecystokinin in adult rats.
    Voits M; Rödel S; Förster S; Plagemann A; Fink H
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):183-92. PubMed ID: 9075266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin receptors do not mediate the suppression of food-motivated behavior by lipopolysaccharide and interleukin-1 beta in mice.
    Bret-Dibat JL; Dantzer R
    Physiol Behav; 2000 May; 69(3):325-31. PubMed ID: 10869599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.
    Rataud J; Darche F; Piot O; Stutzmann JM; Böhme GA; Blanchard JC
    Brain Res; 1991 May; 548(1-2):315-7. PubMed ID: 1868342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors.
    Legido A; Adler MW; Karkanias C; Geller EB; Bradley E; Greenstein JI; Grover WD
    Neuropeptides; 1995 Feb; 28(2):107-13. PubMed ID: 7746354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
    Li BH; Rowland NE
    Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
    Eberle-Wang K; Simansky KJ
    Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the CCK receptor antagonist MK-329 on food intake in pigs.
    Ebenezer IS; de la Riva C; Baldwin BA
    Physiol Behav; 1990 Jan; 47(1):145-8. PubMed ID: 2326329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
    Mercer JG; Lawrence CB
    Neurosci Lett; 1992 Mar; 137(2):229-31. PubMed ID: 1374868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice.
    Barrachina MD; Martínez V; Wang L; Wei JY; Taché Y
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10455-60. PubMed ID: 9294232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
    Wunderlich GR; DeSousa NJ; Vaccarino FJ
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin octapeptide decreases food intake in white-crowned sparrows.
    Richardson RD; Boswell T; Weatherford SC; Wingfield JC; Woods SC
    Am J Physiol; 1993 May; 264(5 Pt 2):R852-6. PubMed ID: 8498593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCH 23390-induced hypophagia is blocked by the selective CCK-A receptor antagonist devazepide, but not by the CCK-B/gastrin receptor antagonist L-365,260.
    Cooper SJ; Barber DJ
    Brain Res Bull; 1990 Apr; 24(4):631-3. PubMed ID: 2141538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.